# Miyako Capital

> Miyako Capital is a VC fund in Kyoto backing Medical and Biotechnology. See 52 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Kyoto, Japan
- Total investments: 52
- Last investment: Aug 2025
- Lead investor: 19%
- Fund size: $1.4B
- Last fund: Dec 2019
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/miyako-capital
- X (Twitter): http://twitter.com/miyakocapital
- Website: http://www.miyakocapital.com
- Facebook: http://www.facebook.com/miyakocapital

Miyako Capital is a VC fund in Kyoto focused on Medical and Biotechnology. Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.

## Contacts

5 contacts available for Miyako Capital. Shizune tracks 6 team members at Miyako Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/miyako-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $750k–$43M |
| Series A | $4.8M–$50M |
| Series B | $3.7M–$354M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 12 | 23% |
| Biotechnology | 12 | 23% |
| Information Technology | 7 | 13% |
| Software | 6 | 12% |
| Health Care | 6 | 12% |

80 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 13 | 25% |
| Seed | 11 | 21% |
| Series B | 9 | 17% |
| Series C | 5 | 10% |
| Funding Round | 5 | 10% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 35 | 67% |
| United States | 4 | 8% |
| United Kingdom | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| He Rui | Principle | 1 | https://shizune.co/investors/profile/mr-he-rui |
| Hiroaki Okahashi | Co-Partner & Co-Founder | 7 | https://shizune.co/investors/profile/hiroaki-okahashi-ccc1 |
| Junko Sugaya | Director and Partner | 1 | https://shizune.co/investors/profile/junko-sugaya |
| Satoshi Yamaguchi | Co-Partner & Co-Founder | 0 | https://shizune.co/investors/profile/satoshi-yamaguchi-b294 |
| Sunny Sugaya | Managing Director | 2 | https://shizune.co/investors/profile/sunny-sugaya |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Fermelanta | Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption. | $13.6M | Series A | Aug 29, 2025 |  |
| Mui Lab | Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle. |  | Series B | Aug 07, 2025 |  |
| XFOREST Therapeutics | xFOREST Therapeutics develops a drug discovery platform that targets RNA structures. | $6.1M | Series A | Jan 24, 2025 |  |
| XFOREST Therapeutics | xFOREST Therapeutics develops a drug discovery platform that targets RNA structures. | $6.1M | Series A | Jan 24, 2025 |  |
| Oishii | Oishii Farm provides indoor vertical farming technology. Oishii sells via supermarkets, offering a container of between eight and 11 strawberries for $50 per package. Hiroki Koga and Brendan Somerville started the company in 2017. | $19.5M | Series B | Dec 17, 2024 |  |
| Peds3 | Peds3 is a digital healthcare platform that specializes in the research and development of pediatric medicine and maternal and child health fields. | $750.5K | Seed | Oct 02, 2024 |  |
| Innovative Space Carrier | Innovative Space Carrier is a aerospace company that offers space transportation systems, planning, drafting and technology strategies. | $2.5M | Seed | Sep 10, 2024 |  |
| Sakana AI | Sakana AI creates a new kind of foundation model based on nature-inspired intelligence. | $209.3M | Series A | Sep 04, 2024 |  |
| Orange | Orange is a developer of a variety of deep-learning models with a focus on computer vision and natural language processing for comics. | $19M | Seed | May 06, 2024 |  |
| Oishii | Oishii Farm provides indoor vertical farming technology. Oishii sells via supermarkets, offering a container of between eight and 11 strawberries for $50 per package. Hiroki Koga and Brendan Somerville started the company in 2017. | $150M | Series B | Feb 27, 2024 |  |

10 of 52 investments shown.

## Co-investors
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund, 10 deals together
- [UTEC - The University of Tokyo Edge Capital Partners](https://shizune.co/investors/profile/utec) — VC Fund, 10 deals together
- [KSP](https://shizune.co/investors/profile/ksp) — VC Fund, 8 deals together
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 7 deals together
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund, 6 deals together
- [Kyoto University Innovation Capital](https://shizune.co/investors/profile/kyoto-university-innovation-capital) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Japan](https://shizune.co/investors/biotechnology-investors-japan)
- [Biotechnology VC Funds in Japan](https://shizune.co/investors/biotechnology-vc-funds-japan)
- [Health Care Investors in Japan](https://shizune.co/investors/health-care-investors-japan)
- [Health Care VC Funds in Japan](https://shizune.co/investors/health-care-vc-funds-japan)
- [Biotech VC Funds in Japan](https://shizune.co/investors/biotech-vc-funds-japan)
- [Medical Investors in Japan](https://shizune.co/investors/medical-investors-japan)

## FAQ

### What does Miyako Capital invest in?

Miyako Capital invests primarily in Medical, Biotechnology and Information Technology startups, most often at Series A and Seed stage. Most of the 52 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Miyako Capital's check size?

Miyako Capital typically joins rounds of $750k–$43M at Seed, $4.8M–$50M at Series A and $3.7M–$354M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Miyako Capital participates in.

### How do I contact Miyako Capital?

Public channels for Miyako Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Miyako Capital?

The team at Miyako Capital includes He Rui (Principle), Hiroaki Okahashi (Co-Partner & Co-Founder) and Junko Sugaya (Director and Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co